SightLife Surgical and AcuFocus today announced the companies have agreed to terms for SightLife to acquire the Kamra inlay from AcuFocus.
The Kamra is the first FDA-approved inlay for the surgical correction of presbyopia.
“As we’ve monitored the progress made in the corneal inlay market, we have been impressed with the AcuFocus team and their Kamra inlay technology,” Monty Montoya, CEO of SightLife Surgical, said in a press release on the acquisition. “We look forward to adding this proven technology to SightLife Surgical and carrying forward the development of this
Uncategorized